Patient Guide: An Extension Study to Learn About the Long-Term Safety of Fazirsiran and if Fazirsiran Can Help People With Alpha-1 Antitrypsin Liver Disease

Why Use Quri.ai for This Trial?

  • ✓ Simplified eligibility checker - know if you qualify in minutes
  • ✓ Direct contact with study coordinators at 10 locations
  • ✓ Plain language explanations of medical terms and procedures
  • ✓ Personalized enrollment support throughout your journey
  • ✓ Free service - no hidden fees or obligations
Trial ID: NCTNCT05899673
Status: ACTIVE_NOT_RECRUITING
Condition: Alpha1-Antitrypsin Deficiency
Phase: PHASE3

Where You Can Participate

This study is available at 10 locations across the country.

Top locations include:
  • • La Jolla, California
  • • Redwood City, California
  • • Gainesville, Florida
  • • And 7 more locations

Loading interactive enrollment tools...

The full interactive experience will load momentarily

An Extension Study to Learn About the Long-Term Safety of Fazirsiran and if Fazirsiran Can Help People With Alpha-1 Antitrypsin Liver Disease - Join Clinical Trial NCTNCT05899673

How to Join This Clinical Trial - NCTNCT05899673

Learn how to participate in this PHASE3 trial studying an investigational therapy for Alpha1-Antitrypsin Deficiency. Current status: ACTIVE_NOT_RECRUITING.

Am I Eligible for This Clinical Trial?

This clinical research study is looking for participants with Alpha1-Antitrypsin Deficiency. Eligibility requirements include specific age ranges, health status, and medical history. Contact the study team to learn if you qualify.

Condition Being Studied
Alpha1-Antitrypsin Deficiency
Treatment Being Tested
Investigational treatment
Study Phase
PHASE3 - Large-scale efficacy study
Enrollment Status
ACTIVE_NOT_RECRUITING
Study Identifier
NCTNCT05899673 - ClinicalTrials.gov Identifier
Sponsored By
Study sponsor

What to Expect as a Participant

Participating in this clinical trial involves:

  • Initial screening to determine eligibility
  • Regular study visits and health assessments
  • Receiving the study treatment or placebo
  • Medical monitoring and follow-up care
  • Contributing to medical research that may help others
  • Potential access to new treatments before they're widely available

Clinical Trial Benefits and Compensation

Participants in this clinical research study may receive:

  • Close medical monitoring by healthcare professionals
  • Access to potential new treatments
  • Compensation for time and travel (varies by study)
  • No-cost study-related medical care
  • The opportunity to help advance medical knowledge

Where Is This Clinical Trial Located?

This study is enrolling participants at 10 locations. Find a study site near you:

Clinical Research Site

La Jolla, California 92037-1337 - United States

Status: Contact for availability

Clinical Research Site

Redwood City, California 94063 - United States

Status: Contact for availability

Clinical Research Site

Gainesville, Florida 32610-3010 - United States

Status: Contact for availability

Clinical Research Site

Iowa City, Iowa 52242-1009 - United States

Status: Contact for availability

Clinical Research Site

Charleston, South Carolina 29425-8900 - United States

Status: Contact for availability

Clinical Research Site

Vienna, A-1090 - Austria

Status: Contact for availability

Clinical Research Site

Aachen, North Rhine-Westphalia 52074 - Germany

Status: Contact for availability

Clinical Research Site

Funchal, 9000-168 - Portugal

Status: Contact for availability

Clinical Research Site

Cambridge, CB2 0QQ - United Kingdom

Status: Contact for availability

Clinical Research Site

Edinburgh, EH16 4SA - United Kingdom

Status: Contact for availability

How to Enroll in This Study

To learn more about participating in this PHASE3 clinical trial for Alpha1-Antitrypsin Deficiency:

  1. Review the eligibility criteria with your healthcare provider
  2. Contact the study team for a pre-screening interview
  3. Schedule an in-person screening visit if eligible
  4. Review and sign the informed consent form
  5. Begin participation in the clinical trial

Why Choose Quri.ai Study Finder

Quri.ai's Study Finder is the leading clinical trial business intelligence platform, helping BD professionals:

  • Discover clinical trials before competitors
  • Access exclusive contact information
  • Track sponsor pipelines and opportunities
  • Connect with decision makers directly
  • Win more business partnerships